132 related articles for article (PubMed ID: 32547205)
1. The Effect of Hormone Therapy on the Expression of Prostate Cancer and Multi-Epigenetic Marker Genes in a Population of Iranian Patients.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Cancer Manag Res; 2020; 12():3691-3697. PubMed ID: 32547205
[TBL] [Abstract][Full Text] [Related]
2. Investigation of GSTP1 and epigenetic regulators expression pattern in a population of Iranian patients with prostate cancer.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Hum Antibodies; 2020; 28(4):327-334. PubMed ID: 32831196
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of RASSF1 promoter methylation in prostate cancer.
Daniunaite K; Jarmalaite S; Kalinauskaite N; Petroska D; Laurinavicius A; Lazutka JR; Jankevicius F
J Urol; 2014 Dec; 192(6):1849-55. PubMed ID: 24980613
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
5. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
[TBL] [Abstract][Full Text] [Related]
6. GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.
Divyya S; Naushad SM; Murthy PV; Reddy ChR; Kutala VK
Mol Biol Rep; 2013 Oct; 40(10):5541-50. PubMed ID: 23979608
[TBL] [Abstract][Full Text] [Related]
7. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
Haluskova J; Lachvac L; Nagy V
Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
[TBL] [Abstract][Full Text] [Related]
8. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
[TBL] [Abstract][Full Text] [Related]
10. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.
Stewart GD; Van Neste L; Delvenne P; Delrée P; Delga A; McNeill SA; O'Donnell M; Clark J; Van Criekinge W; Bigley J; Harrison DJ
J Urol; 2013 Mar; 189(3):1110-6. PubMed ID: 22999998
[TBL] [Abstract][Full Text] [Related]
12. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
13. GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.
Chiam K; Centenera MM; Butler LM; Tilley WD; Bianco-Miotto T
PLoS One; 2011; 6(9):e25634. PubMed ID: 21980513
[TBL] [Abstract][Full Text] [Related]
14. Reduced Rate of Repeated Prostate Biopsies Observed in ConfirmMDx Clinical Utility Field Study.
Wojno KJ; Costa FJ; Cornell RJ; Small JD; Pasin E; Van Criekinge W; Bigley JW; Van Neste L
Am Health Drug Benefits; 2014 May; 7(3):129-34. PubMed ID: 24991397
[TBL] [Abstract][Full Text] [Related]
15. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
16. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
17. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
[TBL] [Abstract][Full Text] [Related]
18. Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach.
Starlard-Davenport A; Kutanzi K; Tryndyak V; Word B; Lyn-Cook B
J Carcinog; 2013; 12():15. PubMed ID: 23961262
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic risk score improves prostate cancer risk assessment.
Van Neste L; Groskopf J; Grizzle WE; Adams GW; DeGuenther MS; Kolettis PN; Bryant JE; Kearney GP; Kearney MC; Van Criekinge W; Gaston SM
Prostate; 2017 Sep; 77(12):1259-1264. PubMed ID: 28762545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
